5
total announcements
532612.BO · 15 min delayed
Indoco Remedies Ltd
Indoco Remedies Ltd has published its unaudited standalone and consolidated financial results for the quarter ended 30-06-2026, showing a net profit of Rs. 8,232 lakhs and a total income of Rs. 40,897 lakhs.
Indoco Remedies Ltd
Indoco Remedies Ltd has made available the audio recording of its earnings conference call for the quarter ended 30-06-2026, which was held on 28th July, 2026. The recording is available on the company's website.
Indoco Remedies Ltd
Indoco Remedies Ltd has announced the re-appointment of Ms. Aditi Panandikar as Managing Director for a period of 5 years, subject to shareholder approval, and the appointment of Mr. Sudhir Kadam as Senior Management Personnel.
Indoco Remedies Ltd
Indoco Remedies Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026, with a net profit of Rs. 8,232 lakhs and a revenue from operations of Rs. 40,897 lakhs. The company has also completed the slump sale of its Ophthalmic Business Division to Sunways (India) Private Limited, resulting in a gain of Rs. 9,734 lakhs.
Indoco Remedies Ltd
Indoco Remedies Ltd has announced its unaudited standalone financial results for the quarter ended 30th June, 2026. The company has reported a profit of Rs. 8,232 lakhs for the quarter, with a total income from operations of Rs. 40,897 lakhs. The statutory auditors have expressed an unmodified audit opinion on these unaudited financial results. The company has completed the slump sale of its Ophthalmic Business Division to Sunways (India) Private Limited, resulting in a gain of Rs. 9,734 lakhs, which has been recognized as an Exceptional Item.